Adam SIDDIQUI-JAIN

Person

South Jordan, UT, US

People

Patents Grantslast 30 patents

Information Patent Grant
CDK9 inhibitors and polymorphs thereof for use as agents for treatm...
- Patent number 12,077,554
- Issue date Sep 3, 2024
- Sumitomo Pharma Oncology, Inc.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ALK-5 inhibitors and uses thereof
- Patent number 11,746,103
- Issue date Sep 5, 2023
- Sumitomo Pharma Oncology, Inc.
- Bettina Franz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof
- Patent number 11,529,350
- Issue date Dec 20, 2022
- Sumitomo Pharma Oncology, Inc.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDK9 inhibitors and polymorphs thereof for use as agents for treatm...
- Patent number 11,530,231
- Issue date Dec 20, 2022
- Sumitomo Pharma Oncology, Inc.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment regimen for cancers that are insensitive to BCL-2 inhibit...
- Patent number 11,497,756
- Issue date Nov 15, 2022
- Sumitomo Pharma Oncology, Inc.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formulations comprising heterocyclic protein kinase inhibitors
- Patent number 11,471,456
- Issue date Oct 18, 2022
- Sumitomo Pharma Oncology, Inc.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
AXL kinase inhibitors and use of the same
- Patent number 11,400,091
- Issue date Aug 2, 2022
- Sumitomo Pharma Oncology, Inc.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Alvocidib prodrugs and their use as protein kinase inhibitors
- Patent number 11,279,694
- Issue date Mar 22, 2022
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antimitotic amides for the treatment of cancer and proliferative di...
- Patent number 11,129,813
- Issue date Sep 28, 2021
- Frost Biologic, Inc.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating diseases associated with abnormal ACVR1 expres...
- Patent number 11,040,038
- Issue date Jun 22, 2021
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDK9 inhibitors and polymorphs thereof for use as agents for treatm...
- Patent number 11,034,710
- Issue date Jun 15, 2021
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
AXL kinase inhibitors and use of the same
- Patent number 11,013,741
- Issue date May 25, 2021
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
AXL kinase inhibitors and use of the same
- Patent number 10,888,562
- Issue date Jan 12, 2021
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination therapies for treatment of cancer
- Patent number 10,835,537
- Issue date Nov 17, 2020
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antimitotic amides for the treatment of cancer and proliferative di...
- Patent number 10,772,872
- Issue date Sep 15, 2020
- Frost Biologic, Inc.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination therapies for treatment of cancer
- Patent number 10,682,356
- Issue date Jun 16, 2020
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapies for treatment of cancer
- Patent number 10,568,887
- Issue date Feb 25, 2020
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alvocidib prodrugs having increased bioavailability
- Patent number 10,562,925
- Issue date Feb 18, 2020
- Tolero Pharmaceuticals, Inc.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Profiling peptides and methods for sensitivity profiling
- Patent number 10,422,788
- Issue date Sep 24, 2019
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Profiling peptides and methods for sensitivity profiling
- Patent number 10,267,787
- Issue date Apr 23, 2019
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Alvocidib prodrugs having increased bioavailability
- Patent number 10,259,835
- Issue date Apr 16, 2019
- Tolero Pharmaceuticals, Inc.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Profiling peptides and methods for sensitivity profiling
- Patent number 10,132,797
- Issue date Nov 20, 2018
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antimitotic amides for the treatment of cancer and proliferative di...
- Patent number 10,016,398
- Issue date Jul 10, 2018
- Frost Biologic, Inc.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alvocidib prodrugs having increased bioavailability
- Patent number 9,758,539
- Issue date Sep 12, 2017
- Tolero Pharmaceuticals, Inc.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinobenzoxazine analogs
- Patent number 7,612,063
- Issue date Nov 3, 2009
- Cylene Pharmaceuticals, Inc.
- Jeffrey P. Whitten
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinobenzoxazine analogs and methods of using thereof
- Patent number 7,507,727
- Issue date Mar 24, 2009
- Cylene Pharmaceuticals, Inc.
- Jeffrey P. Whitten
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for regulating transcription by targeting quadruplex DNA
- Patent number 7,405,041
- Issue date Jul 29, 2008
- Arizona Board of Regents on behalf of the University of Arizona
- Scot W. Ebbinghaus
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinobenzoxazine analogs
- Patent number 7,381,720
- Issue date Jun 3, 2008
- Cylene Pharmaceuticals, Inc.
- Jeffrey P. Whitten
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinobenzoxazine analogs
- Patent number 7,354,916
- Issue date Apr 8, 2008
- Cylene Pharmaceuticals
- Jeffrey P. Whitten
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinobenzoxazine analogs
- Patent number 7,326,702
- Issue date Feb 5, 2008
- Cylene Pharmaceuticals, Inc.
- Jeffrey P. Whitten
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
IMIDAZO[1,2-B]PYRIDAZINYL COMPOUNDS AND USES THEREOF
- Publication number 20240360135
- Publication date Oct 31, 2024
- Sumitomo Pharma Oncology, Inc.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALK-5 Inhibitors and Uses Thereof
- Publication number 20240197729
- Publication date Jun 20, 2024
- Sumitomo Pharma Oncology, Inc.
- Bettina Franz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatm...
- Publication number 20230250116
- Publication date Aug 10, 2023
- Sumitomo Pharma Oncology, Inc.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS
- Publication number 20230233557
- Publication date Jul 27, 2023
- Sumitomo Pharma Oncology, Inc.
- Steven L. WARNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AXL KINASE INHIBITORS AND USE OF THE SAME
- Publication number 20230165857
- Publication date Jun 1, 2023
- Sumitomo Pharma Oncology, Inc.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINOPYRIMIDINYLAMINOBENZONITRILE DERIVATIVES AS NEK2 INHIBITORS
- Publication number 20230090742
- Publication date Mar 23, 2023
- Sumitomo Pharma Oncology, Inc.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AXL INHIBITOR FORMULATIONS
- Publication number 20220380348
- Publication date Dec 1, 2022
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALK-5 INHIBITORS AND USES THEREOF
- Publication number 20220315563
- Publication date Oct 6, 2022
- Bettina Franz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PKM2 MODULATORS AND METHODS FOR THEIR USE
- Publication number 20220162200
- Publication date May 26, 2022
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIMITOTIC AMIDES FOR THE TREATMENT OF CANCER AND PROLIFERATIVE DI...
- Publication number 20220008395
- Publication date Jan 13, 2022
- FROST BIOLOGIC, INC.
- Adam SIDDIQUI-JAIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatm...
- Publication number 20210332071
- Publication date Oct 28, 2021
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DEUTERATED ALVOCIDIB AND ALVOCIDIB PRODRUGS
- Publication number 20210277037
- Publication date Sep 9, 2021
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- Adam SIDDIQUI-JAIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Alvocidib Prodrugs Having Increased Bioavailability
- Publication number 20210261585
- Publication date Aug 26, 2021
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPIES FOR TREATMENT OF CANCER
- Publication number 20210228582
- Publication date Jul 29, 2021
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AXL KINASE INHIBITORS AND USE OF THE SAME
- Publication number 20210205304
- Publication date Jul 8, 2021
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof
- Publication number 20210000825
- Publication date Jan 7, 2021
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antimitotic Amides for the Treatment of Cancer and Proliferative Di...
- Publication number 20200397758
- Publication date Dec 24, 2020
- FROST BIOLOGIC, INC.
- Adam SIDDIQUI-JAIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS
- Publication number 20200338076
- Publication date Oct 29, 2020
- TOLERO PHARMACEUTICALS, INC.
- Steven L. WARNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT REGIMEN FOR CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBIT...
- Publication number 20200276215
- Publication date Sep 3, 2020
- TOLERO PHARMACEUTICALS, INC.
- David J. BEARSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK9 INHIBITORS AND POLYMORPHS THEREOF FOR USE AS AGENTS FOR TREATM...
- Publication number 20200255462
- Publication date Aug 13, 2020
- TOLERO PHARMACEUTICALS, INC.
- Adam SIDDIQUI-JAIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PKM2 ACTIVATORS IN COMBINATION WITH REACTIVE OXYGEN SPECIES FOR TRE...
- Publication number 20200237766
- Publication date Jul 30, 2020
- TOLERO PHARMACEUTICALS, INC.
- Adam SIDDIQUI-JAIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES FOR TREATMENT OF CANCER
- Publication number 20200215071
- Publication date Jul 9, 2020
- TOLERO PHARMACEUTICALS, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
- Publication number 20200200737
- Publication date Jun 25, 2020
- TOLERO PHARMACEUTICALS, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
- Publication number 20200131210
- Publication date Apr 30, 2020
- TOLERO PHARMACEUTICALS, INC.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR TREATING DISEASES ASSOCIATED WITH ABNORMAL ACVR1 EXPRES...
- Publication number 20200085823
- Publication date Mar 19, 2020
- TOLERO PHARMACEUTICALS, INC.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES FOR TREATMENT OF CANCER
- Publication number 20200054642
- Publication date Feb 20, 2020
- TOLERO PHARMACEUTICALS, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALVOCIDIB PRODRUGS AND THEIR USE AS PROTEIN KINASE INHIBITORS
- Publication number 20200048228
- Publication date Feb 13, 2020
- TOLERO PHARMACEUTICALS, INC.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
- Publication number 20190177350
- Publication date Jun 13, 2019
- TOLERO PHARMACEUTICALS, INC.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
- Publication number 20190178873
- Publication date Jun 13, 2019
- TOLERO PHARMACEUTICALS, INC.
- David J. Bearss
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIMITOTIC AMIDES FOR THE TREATMENT OF CANCER AND PROLIFERATIVE DI...
- Publication number 20180325871
- Publication date Nov 15, 2018
- FROST BIOLOGIC, INC.
- Adam SIDDIQUI-JAIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Adam SIDDIQUI-JAIN

Person

Patents Grantslast 30 patents

CDK9 inhibitors and polymorphs thereof for use as agents for treatm...

ALK-5 inhibitors and uses thereof

Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof

CDK9 inhibitors and polymorphs thereof for use as agents for treatm...

Treatment regimen for cancers that are insensitive to BCL-2 inhibit...

Formulations comprising heterocyclic protein kinase inhibitors

AXL kinase inhibitors and use of the same

Alvocidib prodrugs and their use as protein kinase inhibitors

Antimitotic amides for the treatment of cancer and proliferative di...

Methods for treating diseases associated with abnormal ACVR1 expres...

CDK9 inhibitors and polymorphs thereof for use as agents for treatm...

AXL kinase inhibitors and use of the same

AXL kinase inhibitors and use of the same

Combination therapies for treatment of cancer

Antimitotic amides for the treatment of cancer and proliferative di...

Combination therapies for treatment of cancer

Combination therapies for treatment of cancer

Alvocidib prodrugs having increased bioavailability

Profiling peptides and methods for sensitivity profiling

Profiling peptides and methods for sensitivity profiling

Alvocidib prodrugs having increased bioavailability

Profiling peptides and methods for sensitivity profiling

Antimitotic amides for the treatment of cancer and proliferative di...

Alvocidib prodrugs having increased bioavailability

Substituted quinobenzoxazine analogs

Substituted quinobenzoxazine analogs and methods of using thereof

Methods for regulating transcription by targeting quadruplex DNA

Substituted quinobenzoxazine analogs

Substituted quinobenzoxazine analogs

Substituted quinobenzoxazine analogs

Patents Applicationslast 30 patents

IMIDAZO[1,2-B]PYRIDAZINYL COMPOUNDS AND USES THEREOF

ALK-5 Inhibitors and Uses Thereof

CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatm...

FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS

AXL KINASE INHIBITORS AND USE OF THE SAME

AMINOPYRIMIDINYLAMINOBENZONITRILE DERIVATIVES AS NEK2 INHIBITORS

AXL INHIBITOR FORMULATIONS

ALK-5 INHIBITORS AND USES THEREOF

PKM2 MODULATORS AND METHODS FOR THEIR USE

ANTIMITOTIC AMIDES FOR THE TREATMENT OF CANCER AND PROLIFERATIVE DI...

CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatm...

DEUTERATED ALVOCIDIB AND ALVOCIDIB PRODRUGS

Alvocidib Prodrugs Having Increased Bioavailability

COMBINATION THERAPIES FOR TREATMENT OF CANCER

AXL KINASE INHIBITORS AND USE OF THE SAME

Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof

Antimitotic Amides for the Treatment of Cancer and Proliferative Di...

FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS

TREATMENT REGIMEN FOR CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBIT...

CDK9 INHIBITORS AND POLYMORPHS THEREOF FOR USE AS AGENTS FOR TREATM...

PKM2 ACTIVATORS IN COMBINATION WITH REACTIVE OXYGEN SPECIES FOR TRE...

COMBINATION THERAPIES FOR TREATMENT OF CANCER

PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING

ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY

METHODS FOR TREATING DISEASES ASSOCIATED WITH ABNORMAL ACVR1 EXPRES...

COMBINATION THERAPIES FOR TREATMENT OF CANCER

ALVOCIDIB PRODRUGS AND THEIR USE AS PROTEIN KINASE INHIBITORS

ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY

PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING

ANTIMITOTIC AMIDES FOR THE TREATMENT OF CANCER AND PROLIFERATIVE DI...